Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration

Individualized treatment regimens may reduce patient burden with satisfactory patient outcomes in neovascular age-related macular degeneration. Intravitreal anti-VEGF drugs are the current gold standard. Fixed monthly injections offer the best visual outcome but this regimen is not commonly followed...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Ophthalmol
Päätekijät: García-Layana, Alfredo, Figueroa, Marta S., Arias, Luis, Araiz, Javier, Ruiz-Moreno, José María, García-Arumí, José, Gómez-Ulla, Francisco, López-Gálvez, María Isabel, Cabrera-López, Francisco, García-Campos, José Manuel, Monés, Jordi, Cervera, Enrique, Armadá, Felix, Gallego-Pinazo, Roberto
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi Publishing Corporation 2015
Aiheet:
Review Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4600506/
https://ncbi.nlm.nih.gov/pubmed/26491550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/412903
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia